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Abstract
Background: Leptospirosis is a worldwide zoonotic infection that has been recognized for decades, but
the problem of the disease has not been fully addressed, particularly in resource-poor, developing
countries, where the major burden of the disease occurs. This paper presents an overview of the current
situation of leptospirosis in the region. It describes the current trends in the epidemiology of leptospirosis,
the existing surveillance systems, and presents the existing prevention and control programs in the Asia
Pacific region.
Methods: Data on leptospirosis in each member country were sought from official national organizations,
international public health organizations, online articles and the scientific literature. Papers were reviewed
and relevant data were extracted.
Results: Leptospirosis is highly prevalent in the Asia Pacific region. Infections in developed countries arise
mainly from occupational exposure, travel to endemic areas, recreational activities, or importation of
domestic and wild animals, whereas outbreaks in developing countries are most frequently related to
normal daily activities, over-crowding, poor sanitation and climatic conditions.
Conclusion: In the Asia Pacific region, predominantly in developing countries, leptospirosis is largely a
water-borne disease. Unless interventions to minimize exposure are aggressively implemented, the
current global climate change will further aggravate the extent of the disease problem. Although trends
indicate successful control of leptospirosis in some areas, there is no clear evidence that the disease has
decreased in the last decade. The efficiency of surveillance systems and data collection varies significantly
among the countries and areas within the region, leading to incomplete information in some instances.
Thus, an accurate reflection of the true burden of the disease remains unknown.
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Background
Leptospirosis is a globally important zoonotic disease [1-
3], most commonly found in tropical or sub-tropical
countries and may be prevalent in both urban and rural
settings. Annual incidence is estimated from 0.1-1 per
100,000 in temperate climates to 10-100 per 100,000 in
the humid tropics. A disease incidence of more than 100
per 100,000 is encountered during outbreaks and in high-
exposure risk groups [4]. Worldwide prevalence rates
remain underestimated [4,5], most likely as a result of the
protean nature of the disease.
Leptospirosis is caused by spirochetes of the genus Lept-
ospira. Leptospires were first identified as the cause of
Weil's disease in Japan, where it was common among coal
miners [6]. The genus Leptospira contains at least 18 spe-
cies classified on the basis of DNA relatedness and more
than 300 serovars based on agglutinating LPS antigens.
Approximately half of the pathogenic serovars belong to L
interrogans or L. borgpetersenii. Saprophytic species such as
L. biflexa occur in the environment, but play no role in dis-
ease.
Rodents and domestic mammals, such as cattle, pigs and
dogs, serve as major reservoir hosts [6-8], but Leptospira
has been isolated from virtually all mammalian species.
Infected animals may excrete leptospires intermittently or
regularly for months or years, or for their lifetime [6]. Vac-
cinated animals may still shed infectious organisms in the
urine [6].
Human infection results from direct or indirect exposure
to the urine of carrier animals. Leptospires gain entry into
the blood stream via cuts, skin abrasions or mucous mem-
branes. Leptospirosis has often been considered as an
occupational disease, but recreational activities and
traveling in endemic countries are also recognized as risk
factors [8,9]. Significant exposure also occurs from nor-
mal daily activities, with high rates of infection during
heavy rainfall and flooding [7,10,11]. Urban slum dwell-
ers in areas with poor sanitation are at particularly high
risk [7]. The epidemiology of leptospirosis is illustrated in
Figure 1.
The spectrum of clinical presentations of human lept-
ospirosis ranges from asymptomatic to fatal. The majority
of infections is subclinical or results in mild self-limiting
systemic illness [10]. However, the case fatality rate in
severe leptospirosis may be as high as 20% [10]. A partic-
ular problem is that that leptospirosis can be misdiag-
nosed, due to its wide spectrum of symptoms which may
mimic the clinical signs of many other diseases, such as
dengue fever, hantavirus infection and malaria.
This review describes the current trends in the epidemiol-
ogy of leptospirosis in the Asia Pacific region, the existing
surveillance systems for leptospirosis in these regions, and
presents the existing prevention and control programs in
the region. Data on the prevalence of leptospirosis in each
country were sought from official national organizations,
international public health organizations, online articles
and the scientific literature. However, the efficiency of sur-
veillance systems and data collection varies significantly
among the countries and areas within the region, leading
to incomplete information in some instances.
Methods
Data were obtained from official national organizations,
international public health organizations, personal com-
munications, MEDLINE, online articles and the scientific
literature. Papers were reviewed and relevant data were
extracted.
Results and discussion
I. Surveillance Systems
Surveillance of leptospirosis has proven to be an effective
public health tool in preventing large outbreaks of the dis-
ease [12]. Whereas effective surveillance systems with
appropriate laboratory support exist in developed coun-
tries in the Asia Pacific region, they are generally lacking
in the disease-endemic, developing countries. Even when
present, the systems may not meet acceptable interna-
tional quality assurance standards. Despite the existence
of the WHO case definition for leptospirosis, the infre-
quent use of confirmatory laboratory testing, and the ina-
bility to link clinical, epidemiologic, and laboratory data
have hindered system utility [9].
A functional disease surveillance system, for both humans
and animals, is essential for the effective control of lept-
ospirosis. In addition to a number of research institutions,
there are three WHO collaborating centers for leptospiro-
sis in the region: the WHO/FAO/OIE Collaborating Cen-
tre for Reference and Research on Leptospirosis, Australia
and Western Pacific Region based in Brisbane, Australia,
and the Regional Medical Research Center in Port Blair,
India.
II. Epidemiology
The actual incidence of leptospirosis in the Asia Pacific
region is not well-documented, similar to the situation in
many regions worldwide. Aside from underreporting,
incidence data are further compromised by the unavaila-
bility of laboratory diagnosis [10]. Within the Asia Pacific
region, Southeast Asia and Oceania appear to have the
highest incidence of leptospirosis [11].
Major outbreaks of the disease in South-East Asia due to
flooding were reported in Orrisa (1999), Jakarta (2003)
and Mumbai (2005). It has been a continuing and signif-
icant problem in the densely populated, flood-prone low
lying areas of India.BMC Infectious Diseases 2009, 9:147 http://www.biomedcentral.com/1471-2334/9/147
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In India, the disease has been found more commonly
associated with natural disasters especially during the
monsoon period at which times acute epidemics may
eventuate [13]. A multi-centric study in India showed that
leptospirosis accounts for about 12.7% of cases of acute
febrile illness responsible for attendance at hospitals [14].
Carrier animals include rats, pigs, cattle, bandicoots and
dogs. The predominant serovars are Copenhageni,
Autumnalis, Pyrogenes, Grippotyphosa, Canicola, Austra-
lis, Javanica, Sejroe, Louisiana, and Pomona. Outbreaks of
leptospirosis have increasingly been reported from Kerala,
Gujarat, Tamil Nadu and Karnataka and sporadic cases
have been reported from Goa, Andhra Pradesh and Assam
[13].
Leptospirosis has been known to be endemic since the
early part of 20th century on the Andaman and Nicobar
Islands, where serovars Ratnapura, Valbuzzi and Grippo-
typhosa have been recently documented as causes of
severe epidemics [15]. Highest rates occur during October
to November, with seroprevalence of up to 55% in the
general population [8]. Interestingly, the predominance
of leptospirosis in coastal regions is most likely correlated
with the presence of semi-domestic brown rats. In the
Epidemiology of leptospirosis Figure 1
Epidemiology of leptospirosis. Carrier animals, domestic or wild, cycle leptospires within the population. Leptospires may 
then be transmitted to humans directly by contact with infected urine or indirectly via contaminated soil or water, especially in 
times of flood. Human leptospirosis constitutes a dead-end infection; human to human transmission is virtually unknown.
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inland urban regions, other serovars with other host ani-
mals/rodents were presumed to cause the 'mild' lept-
ospirosis that is usually unrecognized or misdiagnosed.
The Maldives reported their first confirmed case of
human leptospirosis in November 2000. Since then, the
disease is under national surveillance (Geela Ali-personal
communication. Director, Center for Community Health
and Disease Control, Maldives).
In Bangladesh and Nepal, countries with similar environ-
mental and sanitary conditions to those in India, the
problem of overcrowding also contributes to the burden
of disease [16,17]. A serological survey in a rural flood
prone district of Bangladesh in 1994 showed 38% serop-
ositivity in 89 samples of human sera tested, indicating
that the rural population is at high risk of leptospiral
infection [18]. In 2000, acute-phase serum specimens
from 359 dengue-negative patients in Dhaka were
assessed for leptospirosis; Leptospira was detected by PCR
in 63 (18%) of them. Poverty and poor education were
implicated as conditions leading to rodent-borne trans-
missions [16]. A number of serological studies carried out
in Nepal during the last decade showed the presence of
antibodies against major Leptospira spp. prevalent in Asia.
[17,19,20]. There are no published human leptospirosis
data for Bhutan. However, suspected leptospirosis human
cases have been reported from Chukha district during
summer season after flooding in 2008. Cases commonly
present with a history of fever for 10 days and autopsy
reports indicate organ failure or pulmonary hemorrhage
as cause of death. The National Center for Animal Health
has detected leptospirosis cases among pigs based on pos-
itive serology. (Karma Lhazeen - personal communica-
tion. Programme Officer, Vector-borne Disease Control
Programme, Gelephu, Bhutan)
Increasing numbers of leptospirosis cases have been
observed over recent years in Sri Lanka despite the imple-
mentation of a set of strategies for its control and preven-
tion. It has a reported annual incidence of approximately
14/100,000. Over 19 leptospiral serovars belonging to
over 7 serogroups have been isolated and incriminated as
the causative agents of leptospirosis in humans and/or
animals throughout the country [21]. Peak incidence is
associated with the rice paddy-harvesting seasons wherein
an increase in the rodent population in and around the
fields is observed. The majority of patients [43.5%] had
been exposed in the paddy fields, indicating occupational
exposure among the farmers [21]. In 2007, a total of 2195
cases was reported, 40% more than in the previous year.
An unusually high case fatality rate and high reporting
were noted in districts not previously identified as high
risk areas [22]. This alarming trend has cautioned the Min-
istry of Health to re-assess its on-going strategies on lept-
ospirosis.
In Thailand, data from disease notification reports indi-
cated an increase in the incidence rate from less than 0.3
per 100,000 in 1995 to 23.7 in 2000, with a drop in sub-
sequent years. The vast majority of the cases [90%] was
reported in the Northeast region, primarily as a result of
flooding [23] and the emergence of a highly virulent clone
[24]. A recent seroprevalence study at a hospital on the
Thai-Myanmar border revealed that 17% of patients who
sought treatment for fever were diagnosed with lept-
ospirosis [25]. Most infections occur in agricultural work-
ers, primarily rice producers, whose bare-footed activity
during work in rice fields constitutes the main risk. Out-
breaks of leptospirosis correspond with the rainy season,
with an increase in cases beginning in August and decreas-
ing in November. In Myanmar, veterinary investigations
have reported the presence of leptospirosis in the animal
population [26] while data for human leptospiral cases
are not available.
Leptospirosis probably poses a severe and highly underes-
timated continuous health problem in Indonesia. In
2001, 139 human serum samples were tested out of which
18.7% were positive, indicating predominantly presump-
tive serovar Bataviae infections [27]. In the wake of mas-
sive flooding in Indonesia in January 2002, a leptospirosis
outbreak occurred, notably in the capital Jakarta on Java.
In this outbreak, 12.0% out of 418 samples were seropos-
itive against serovars Bataviae or Hardjo [27]. During this
outbreak, high seropositivity rates were detected among
potential domestic infection reservoirs such as cats, dogs
and cattle. There has been a nationwide increase in the
number of reported human cases since 2006. Out of 667
reported human cases in 2007, 93% were laboratory con-
firmed. The case fatality rate was 8%. In the first quarter of
2008, 269 cases have been detected [Asri Mohammad -
personal communication. WHO country office, Indone-
sia].
A suspected clinical case of leptospirosis was recorded
during the flooding season in Timor-Leste in 2006 but it
could not be confirmed [Sidartha Yuwono - Personal
communication. WHO country office, Timor-Leste].
For the year 2008, the total number of notifications for
Australia was 112 cases [28]. This is the lowest number of
reported cases in over ten years and represents a down-
ward trend since a peak in 1999. This reduction has been
attributed to persistent drought conditions over the last
few years. The northern state of Queensland accounts for
most of the leptospirosis cases in the country [71.2%],
with serovars Zanoni, Australis and Hardjo accounting for
58.9% of these. The disease has been mainly an occupa-
tional hazard of livestock and agricultural workers. Serov-
ars Arborea and Topaz have recently emerged as
significant causes of human leptospirosis. In the southernBMC Infectious Diseases 2009, 9:147 http://www.biomedcentral.com/1471-2334/9/147
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temperate climate states, serovar Hardjo acquired from
cattle constitutes the main infecting serovar.
Leptospirosis is the most common occupationally
acquired infectious disease in New Zealand. The great
majority of cases of leptospirosis occurs among livestock
farm workers and meat processing workers [29]. An
assessment of human leptospiral epidemiology in New
Zealand, conducted by Thornley et al. [30] from 1990
to1998, showed an annual incidence of 4.4 per 100,000
population. However, the analysis of trends over this 9-
year period revealed that a changing epidemiological pat-
tern was evident, with the emergence of L. borgpetersenii
serovar Ballum as a more frequent cause of human infec-
tion.
The Philippines faces a serious problem of leptospirosis.
Poor sanitation and the increase in urban slums along
with frequent typhoons and expansion of flooding areas
in the country have exacerbated the risk of infection [31].
Information on the prevalent Leptospira serovars among
humans in the Philippines dates back to the late 1960s
and 1970s, when antibodies against serovars Pyrogenes,
Bataviae, Pomona, Grippotyphosa, Manilae and Javanica
were detected among high-risk workers such as abattoir
employees, dog pound workers and fish inspectors in
Manila. Outbreaks of leptospirosis due to flooding were
reported in prisons, penal farms and in many parts of the
country [32,33]. Yanagihara et al. [7] performed a seroep-
idemiological survey from 1998 to 2001, showing that
70% of suspected leptospirosis patients (1,200) were sero-
positive. They also isolated leptospires from humans and
rats (both house and field) in metropolitan Manila and
nearby provinces, and also in the city of Iloilo. In 1999,
the Department of Health listed leptospirosis as a notifia-
ble disease in the country.
In Japan, the number of leptospirosis cases had increased,
reaching more than 200 reported deaths annually until
1960 [34,35], mostly in rice-field farmers. Since then, this
number has decreased rapidly, primarily due to the mech-
anization of agriculture in this country, farmers' use of
rubber boots when working in the fields and the use of an
inactivated vaccine [7,10]. Currently, less than 20 human
cases are reported annually, mostly contracted during rec-
reational activities or imported from Southeast Asian
countries, or by contact with imported infected animals
[7,36]. Serovars Icterohaemorrhagiae, Copenhageni,
Autumnalis, Hebdomadis and Australis have been recog-
nized as major causes of human leptospirosis. Most cur-
rent cases are confined to the southernmost islands, the
Okinawa archipelago [7,36].
The first leptospiral case in Korea  was documented in
1984, and since then, it has become recognized as a major
public health problem [37]. Serovars Lai, Copenhageni
and Canicola were isolated from 1984-1990 [38]. A lept-
ospiral vaccination programme was initiated in 1988, tar-
geting high risk groups in the rural areas and may have
been responsible for the reduction of cases in the succeed-
ing years. However, during the last decade, cases have
been increasing slightly. In the year 2007, 208 cases of
human leptospirosis were recorded. The bulk of cases con-
sisted predominantly of rice field farmers, occurred in the
rural areas of Jeonnam and Jeonbuk (Sang-Hee Park - per-
sonal communication, NIH, Korea Center for Disease
Control & Prevention. [39]).
To date, 37 serovars from humans and animals have been
isolated in Malaysia [40]. Human infections in the 1950s,
depicted as febrile cases, were commonly observed in mil-
itary personnel and civilians [40]. Succeeding investiga-
tions revealed that the disease is an occupational hazard
mostly for people engaged in agricultural and livestock
activities, such as cattle farmers, veterinary staff, tin min-
ers, farmers and paddy planters [40]. Recent studies
reported a high enzootic incidence in the animal popula-
tion [40,41]. In 2000, a recreational event-related out-
break of leptospirosis originated in Malaysia [42].
Vietnam,  Cambodia  and  Laos  have been considered
endemic for leptospirosis. In 2002, a study by Laras and
colleagues [43] confirmed the endemicity of the disease in
many areas in these countries. In this study, Hurstbridge,
Bataviae and Icterohaemorrhagiae were reported to be the
predominant serovars identified in patients with clinical
jaundice. Serovar Bataviae, on the other hand, was most
frequently isolated from patients with non-malarial
febrile illness. Pyrogenes and Hurstbridge were the princi-
pal serogroups identified among patients with hemor-
rhagic fever. Recent seroprevalence studies conducted in
flood-prone rural areas in Laos [44] and in southern Viet-
namese children [45] showed an overall seroprevalence of
23.9% and 12.8%, respectively. In a human seropreva-
lence study conducted in the Mekong Delta of Vietnam
(1998), Bataviae was identified as the most common sero-
group [46]. Meanwhile, the highest seroprevalence rate
among sows in the same area was recorded with serovar
Bratislava [47]. A study in Takeo province, Cambodia esti-
mated an annual incidence of 7.65 per 100,000 popula-
tion [48] with Javanica and Australis as the main
serogroups.
Leptospirosis has been notifiable since 1955 in People's
Republic of China. Accumulated evidence from 1955-
1993 showed an annual incidence of 7.1 per 100,000 with
a mortality rate of 1.0% in 26 provinces across the main-
land [Gu J-W, Jiang X-G, Guo X-K, unpublished]. Cases
were concentrated in July to October, particularly in
August and September. Icterohaemorrhagiae and Pomona
are the dominant serogroups frequently associated with
leptospirosis in the country [Gu J-W, Jiang X-G, Guo X-K,BMC Infectious Diseases 2009, 9:147 http://www.biomedcentral.com/1471-2334/9/147
Page 6 of 9
(page number not for citation purposes)
unpublished]. From January 2002 to October 2007, the
Ministry of Health reported about 1,500 confirmed cases
and 50 deaths in mainland China [49]. There is a low inci-
dence of leptospirosis in Hong Kong SAR. There was only
1 local case in 2001, 2 local cases in 2002, 1 imported case
in 2003 and 1 imported and 5 local cases in 2004, 7 in
2005 and 1 in 2006 [50]. Although no published reports
on human leptospirosis in Mongolia can be found, the
disease is most likely endemic, as numerous seropreva-
lence studies indicate a high incidence of animal lept-
ospirosis [51].
In a regional human leptospirosis survey conducted in the
Western Pacific Islands [52], among 263 cases of sus-
pected leptospirosis cases from September 2003 to
December 2005, 69 were confirmed from 7 islands:
Futuna, Raiatea and the Marquesas Islands, where out-
breaks were apparent, and Vanuatu, Fiji, Palau and Wallis
where sporadic cases indicated the presence of the disease.
Icterohaemorrhagiae and Australis were the dominant
presumptive serogroups, indicating linkage to a rodent
reservoir. The rate of exposure has more often been related
to normal daily activities than following a specific occupa-
tional exposure. According to World Organisation for Ani-
mal Health (OIE) data, the disease is enzootic in French
Polynesia and New Caledonia. In a retrospective study of
192 cases of human leptospirosis in New Caledonia from
1989 to 1993, the annual incidence rate was estimated to
be 30 per 100,000 population [53]. Serovar Icterohaem-
orrhagiae was the most prominent among the forty iso-
lates obtained. The annual incidence between 2002 and
2008 has varied from 6.1 to 92 per 100,000, with a large
increase in incidence in 2008 (92/100,000) and with
signs that this will increase further in 2009. Notifications
up to 8 June 2009 were 134, which would equate to an
overall figure of over 150/100,000 if the trend continues
for the remainder of the year.
Leptospirosis has been considered endemic in the Com-
monwealth of the Northern Mariana Islands [54],
although its actual incidence is unknown. Serological evi-
dence in Palau indicates that up to 8 percent of "viral syn-
drome" cases (fever of unknown origin in an adult) were
related to acute leptospirosis [55].American Samoa
reported its first laboratory-confirmed human case in
April 2003. A year later, a seroprevalence survey was con-
ducted, showing that 17% of the enrolled adults have had
prior infection, with Bratislava as the dominant serovar
[56]. Leptospirosis in Papua New Guinea dates back to
the 1970s; however, data collection on the disease is
scarce. A recent investigation in livestock found a domi-
nance of serovar Hardjo [57].
The incidence of leptospirosis in the region is summarized
in Table 1.
III. Prevention and Control
Leptospirosis is a preventable disease. Control measures
must include risk communications, improvement in san-
itation and living conditions, and rodent control, as well
as both prophylactic and therapeutic medical and veteri-
nary interventions.
a. Social control measures
Social control measures are an essential component of
the success of prevention and control of leptospirosis.
Effective risk communication strategies will ensure
that appropriate approaches are used with identified
at-risk groups, but also with the groups that can influ-
ence the knowledge and practices of these at-risk
groups. Such approaches include awareness, health
promotion and health education, advocacy and capac-
ity building.
Leptospirosis has typically been considered an occu-
pational disease and thus social control measures
directed towards agriculture and other at-risk workers
are critical. For instance, a study suggested that the use
of trousers and long skirts among pond cleaners in
Thailand is a strong protective factor against infection
and that further education efforts on protective prac-
tices are needed [58]. Awareness of the disease, partic-
ularly its protean manifestations, and education about
preventative measures with labor organizations and
employers should also be implemented. Intensive,
well-directed education and publicity campaigns in
New Zealand, used in conjunction with a campaign
for immunization of cattle, were successful in reduc-
ing the incidence of leptospirosis [29,30,36].
In urban slums with high levels of poverty, environ-
mental sources of transmission include open refuse
deposits and animal reservoirs, open sewers and
flooding; infection is thus associated with exposure in
and around the household [58]. Several approaches
are needed to reduce risk factors in these situations.
Health education campaigns targeted at household
occupants as well as advocacy on social determinants
of health and concrete actions to reduce health ineq-
uity are also needed. Moreover, awareness and educa-
tion are necessary among administrative, education
and health professionals in human and veterinary
medicine including primary health care workers, wild
life and conservation scientists and infrastructure and
urban planners [6].
b. Rodent control
Rodents are recognized as the most important reser-
voirs in the transmission of leptospirosis [3,10], espe-
cially of more severe forms. Rodent-vector control
activities must consider the epidemiological implica-
tions, ecology, and dynamic population of the rodentsBMC Infectious Diseases 2009, 9:147 http://www.biomedcentral.com/1471-2334/9/147
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[59]. Sample collection of rodent species as well as
documentation of their infestation levels is required
[60]. The use of rodenticides, entrapment of animals,
and improved sanitation have been shown to success-
fully diminish the risk of leptospirosis transmission
[60,61]. In India, the timing of rodent control was
shown to be a vital consideration in the prevention of
disease transmission. The rodent breeding period
starts with the southwest monsoon [60], suggesting
that rodent control measures in the pre-monsoon
period would bring better vector control.
c. Vaccination
On-going research into numerous vaccine prepara-
tions for humans and animals is well documented.
This includes the use of inactivated and attenuated
vaccines, recombinant protein or lipoprotein vaccines,
LPS vaccines and DNA vaccines [62,63].
The local variability in serovars of endemic leptospiral
strains complicates the development of a vaccine that
could be used worldwide [6,10]. Current bacterin vac-
cines elicit immunity that is generally restricted to
serovars with related agglutinating LPS antigens. In the
region, human vaccines against Leptospira are available
in China, Japan, Korea and Vietnam (Sang-Hee Park -
personal communication, NIH, Korea Center for Dis-
ease Control & Prevention. [64]), whereas commercial
Leptospira vaccines for animals are available in many
countries [62,64]. Although treatment and vaccina-
Table 1: Summary of incidence of leptospirosis in the Asia Pacific region.
Annual incidence per 100,000 Country/region
High (>10) Bangladesha
Cambodiaa
Fijia
French Polynesiaa
India (Andaman and Nicobar Islands)
Laosa
Nepala
New Caledonia
Sri Lanka
Thailand
Vietnama
Wallis and Futunaa
Moderate (1 to 10) American Samoaa
China
India (mainland)
Indonesia
Malaysia
New Zealand
Palaua
Philippines
Marshall Islandsa
Vanuatua
Mongoliaa
Low (<1) Australia
Hong Kong SAR
Japan
South Korea
Taiwan
Insufficient information Bhutan
Myanmar
North Korea
Papua New Guinea
Timor-Leste
Western Pacific islands not mentioned above
a based on unofficial information where official data are not availableBMC Infectious Diseases 2009, 9:147 http://www.biomedcentral.com/1471-2334/9/147
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tion of livestock are not mandatory, low sporadic
occurrence of the disease in these animals was
observed in endemic countries after initiation of a vac-
cination program [6,65]. Vaccination of domestic ani-
mals may be considered too expensive in developing
countries, and, in any event, may not prevent lept-
ospiruria in vaccinated animals [6]. Clearly, vaccina-
tion is not possible for non-domestic reservoir
animals.
d. Chemoprophylaxis
Use of doxycycline as a prophylactic measure has been
reported [6], but is clearly only suitable in instances
where exposure can be predicted accurately and is for
a short period of time. It is not appropriate as a rou-
tine, long term, community-based practice.
Conclusion
Leptospirosis remains a major endemic environmental
disease in most countries in the Asia Pacific Region. Socio-
economic conditions, population density, climatic and
environmental conditions, and behavioral and occupa-
tional habits of humans are determinants of the incidence
and prevalence of the disease. The ability of all countries
in the region to accurately report and monitor leptospiro-
sis hinges strongly on their respective capacity to provide
accurate and reliable diagnostic and reporting services.
Leptospirosis is preventable. Host/reservoir control meas-
ures, environmental control programs and animal vacci-
nation, in conjunction with a strong surveillance system
may significantly reduce, if not eliminate, the disease.
Thus, an effective collaboration among countries in the
region is the key to successfully combating this public
health problem.
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